Skip to main content

Advertisement

SpringerLink
Log in

Celiac disease—A worldwide problem

  • Symposium: Gastroenterology-I
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Celiac disease and dermatitis herpetiformis are caused by the alcohol soluble fractions of wheat, barley, and rye. Reliable serological tests are available for both mass and risk group screening and recent epidemiological studies on celiac disease suggest that the prevalence varies between 1 : 100–300 in different continents. The clinical manifestations of the disease has changed in the West and the classical symptomatic cases represent only approximately 1/7th of all diagnosed cases. Symptoms such as, anemia, short stature, dental enamel defect or osteoporosis can be the only manifestations of the atypical disease. There is an increased prevalence of celiac disease in patients with autoimmune diseases. Recent data suggest that there is a correlation between the prevalence of autoimmune diseases and the number of years that an individual consumes, gluten-containing foods. Genetic studies revealed a high prevalence of certain HLA antigens in celiac patients, however, there is likelihood that non-HIA genes are also important in the pathomechanism. An interesting new development is the recognition of tissue transglutaminase (tTG), an enzyme that probably forms an autoantigen with gluten. It is generally accepted that antibodies to tTG are identical to the previously described antiendomysium antibodies. Whether or not tTG is responsible for the initiation of an immunoreaction against prolamines or just exacerbates the immune response is a subject of further investigations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Janatuinen EK, Pikkarainen PH, Kemppainen TA, Kosma VM, Jarvinen RM, Uusitupa Mlet al. A comparison of diets with and without oats in adults with celiac disease.N Engl J Med 1995; 333: 1033–1037.

    Article  PubMed  CAS  Google Scholar 

  2. Srinivasan U, Leonard N, Jones E, Kasarda DD, Weir DG, O’Farrelly Cet al. Absence of oats toxkity in adult celiac disease.BMJ 1996; 313: 1300–1301.

    PubMed  CAS  Google Scholar 

  3. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis.Gastroenterology 1993; 105 : 910–922.

    PubMed  CAS  Google Scholar 

  4. Kagnoff MF. Celiac disease. A gastrointestinal disease with environmental, genetic, and immunologic components.Gastroenterol Clin North Am 1992; 21: 405–425.

    PubMed  CAS  Google Scholar 

  5. Petronzelli F, Bonamico M, Ferrante P, Grillo R, Mora B, Mariani Pet al. Genetic contribution of the HLA region to the familial clustering of celiac disease.Ann Hum Genet 1999; 36: 307–317.

    Google Scholar 

  6. Bevan S. Popat S, Braegger CP, Busch A, O’Donoghue D, Falth-Magnusson Ket al. Contribution of the MHC region to the familial risk of celiac disease.J Med Genet 1999; 36: 687–690.

    PubMed  CAS  Google Scholar 

  7. Balas A, Vicario JI, Zambrano A, Acuna D. Absolute linkage of celiac disease and dermatitis herpetiformis to HLA-DQ.Tissue Antigens 1997; 50: 52–56.

    PubMed  CAS  Google Scholar 

  8. Chorzelski Tp, Beutner EH, Sulej J, Tchorzewska H, Jablonska S, Kumar Vet al. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and celiac disease.Br J Dermatol 1984; 111: 395–402.

    Article  PubMed  CAS  Google Scholar 

  9. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EOet al. Identification of tissue transglutaminase as the autoantigen of celiac disease.Nature Medicine 1997; 3: 797–801.

    Article  PubMed  CAS  Google Scholar 

  10. Maki M, Kallonen K, Lahdeaho Ml, Visakorpi JK. Changing pattern of childhood celiac disease in Finland.Acta Paediatr Scand 1988; 77: 408–412.

    PubMed  CAS  Google Scholar 

  11. Catassi C, Fabiani E, Ratsch IM, Coppa GV, Giorgi PL, Pierdomenico Ret al. The celiac iceberg in Italy. A multicentre antigliadin antibodies screening for celiac disease in school-age subjects.Acta Paediatrica 1996; 412: 29–35.

    CAS  Google Scholar 

  12. Vajro P, Fontanella A, Mayer M, De Vincenzo A, Terracciano LM, D’Armiento Met al. Elevated serum aminotransferase activity as an early manifestation of gluten-sensitive enteropathy.J Pediatr 1993; 122: 416–418.

    Article  PubMed  CAS  Google Scholar 

  13. Ciacci C, Cirillo M, Auriemma G, Di Dato G, Sabbatini F, Mazzacca G. Celiac disease and pregnancy outcome.Am J Gastroenterol; 1996; 91: 718–722.

    PubMed  CAS  Google Scholar 

  14. Marsh MN, Crowe PT. Morphology of the mucosal lesion in gluten sensitivity.Baillieres Clin Gastroenterol 1995; 9: 273–293.

    Article  PubMed  CAS  Google Scholar 

  15. Not T, Horvath K, Hill ID, Partanen J, Hammed A, Magazzu Get al. Celiac disease risk in the USA: High prevalence of antiendomysium antibodies in healthy blood donors.Scand Gastroenterol 1998; 33 : 494–498.

    Article  CAS  Google Scholar 

  16. Sher KS, Fraser RC, Wicks AC, Mayberry JF. High risk of celiac disease in Punjabis. Epidemiological study in the south Asian and European populations of Leicestershire.Digestion 1993; 54: 178–182.

    PubMed  CAS  Google Scholar 

  17. Khoshoo V, Bhan MK. Celiac disease in Indian children.Indian Pediatr 1989; 26: 627–629.

    PubMed  CAS  Google Scholar 

  18. Bitar JG, Salem AA, Nasr AT. Celiac disease from the Middle East.J Med Liban 1970; 23: 423–444.

    PubMed  CAS  Google Scholar 

  19. Dawood FH, Jabbar AA, Al-Mudaris AF, Al-Hasani MH. Association of HLA antigens with celiac disease among Iraqi children.Tissue Antigens 1981; 18: 35–39.

    PubMed  CAS  Google Scholar 

  20. Abdullah AM. Aetiology of chronic diarrhoea in children: experience at King Khalid University Hospital, Riyadh, Saudi Arabia.Ann Trap Paediatr 1994; 14 : 111–117.

    CAS  Google Scholar 

  21. Suliman GI. Celiac disease in Sudanese children.Gut 1978; 19: 121–125.

    Article  PubMed  CAS  Google Scholar 

  22. Boudraa G, Hachelaf W, Benbouabdellah M, Belkadi M, Benmansour FZ, Touhami M. Prevalence of celiac disease in diabetic children and their first-degree relatives in west Algeria: Screening with serological markers.Acta Paediatr Suppl 1996; 412 : 58–60.

    Article  PubMed  CAS  Google Scholar 

  23. Cooper BT, Holmes GK, Cooke WT. Celiac disease and immunological disorders.Br Med J 1978; 1: 537–539.

    Article  PubMed  CAS  Google Scholar 

  24. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune disorders in Celiac Disease.Gastroenterology 1999; 117: 297–303.

    Article  PubMed  CAS  Google Scholar 

  25. Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers Met al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies.J Autoimmun 1999; 13: 143–148

    Article  PubMed  CAS  Google Scholar 

  26. Bardella MT, Vecchi M, Conte D, Del Ninno E, Fraquelli M, Pacchettiet al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease.Hepatology 1999; 29: 654–657.

    Article  PubMed  CAS  Google Scholar 

  27. Berti I, Trevisiol C, Tommasini A, Citta A, Neri E, Geatti Oet al. Usefulness of screening program for celiac disease in autoimmune thyroiditis.Dig Dis Sci 2000; 45: 403–406

    Article  PubMed  CAS  Google Scholar 

  28. Sturgess R, Day P, Ellis HJ, Lundin KE, Gjertsen HA, Kontakou Met al. Wheat peptide challenge in celiac disease.Lancet 1994; 343: 758–761.

    Article  PubMed  CAS  Google Scholar 

  29. Shidrawi RG, Day P, Przemioslo R, Ellis HJ, Nelufer JM, Ciclitira PJ. In vitro toxicity of gluten peptides in celiac disease assessed by organ culture.Scand J Gastroenterol 1995; 30: 758–763.

    PubMed  CAS  Google Scholar 

  30. Kontakou M, Przemioslo RT, Sturgess RP, Limb GA, Ellis HJ, Day Pet al. Cytokine mRNA expression in the mucosa of treated celiac patients after wheat peptide challenge.Gut 1995; 37: 52–57.

    Article  PubMed  CAS  Google Scholar 

  31. Graf L, Horvath K, Walcz E, Berzetei I, Burnier J. Effect of two synthetic alphagliadin peptides on lymphocytes in celiac disease: Identification of a novel class of opioid receptors.Neuropeptides 1987; 9 : 113–122

    Article  PubMed  CAS  Google Scholar 

  32. Payan DG, Horvath K, Graf L. Specific high-affinity binding sites for a synthetic gliadin heptapeptide on human peripheral blood lymphocytes.Life Sci 1987; 40: 1229–1236.

    Article  PubMed  CAS  Google Scholar 

  33. Horvath K, Graf L, Walcz E, Bodanszky H, Schuler D. Naloxone antagonises effect of alpha-gliadin on leucocyte migration in patients with celiac disease.Lancet 1985; 2: 184–185.

    Article  PubMed  CAS  Google Scholar 

  34. Maki M, Holm K, Lipsanen V, Hallstrom O, Viander M, Collin Pet al. Serological markers and HLA genes among healthy first-degree relatives of patients with celiac disease.Lancet 1991; 3338: 1350–1353

    Article  Google Scholar 

  35. Auriccihio S, Magazzu G, Tosi Ret al. Celiac disease as a familial condition: Identification of asymptomatic celiac patients within family groups.Gastroenterol Internat 1988; 1 : 25–31

    Google Scholar 

  36. Mazzilli MC, Ferrante P, Mariani P, Martone E, Petronzelli F, Triglioneet al. A study of Italian pediatric celiac disease patients confirms that the primary HLA association is to the DQ (alpha 1*0501, beta 1* 0201) heterodimer.Hum Immunol 1992; 33: 133–139.

    Article  PubMed  CAS  Google Scholar 

  37. Sollid LM, Molberg O, McAdam S, Lundin KE. Autoantibodies in celiac disease: Tissue transglutaminase-guilt by association?Gut 1997; 41 : 851–852.

    Article  PubMed  CAS  Google Scholar 

  38. Van de Wai Y, Kooy YM, van Veelen PA, Pena SA, Mearin LM, Molberget al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin.Proc Natl Acad Sci USA 1998; 95: 10050–10054.

    Article  Google Scholar 

  39. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausaet al. Gliadinspecific, HLS-DQ (alpha 1*0501, beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.J Exp Med 1993; 178: 187–196.

    Article  PubMed  CAS  Google Scholar 

  40. Molberg O, McAdam SN, Sollid LM. Role of tissue transglutaminase in celiac disease.J Pediatr Gastroenterol Nutr 2000; 30: 232–240.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Gastroenterology and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA

    Karoly Horvath M.D. Ph.D.

  2. Division of Pediatric Gastroenterology and Nutrition, A.I. duPont Institute, Wilmington, Delaware, USA

    Devendra I. Mehta

Authors
  1. Karoly Horvath M.D. Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Devendra I. Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karoly Horvath M.D. Ph.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horvath, K., Mehta, D.I. Celiac disease—A worldwide problem. Indian J Pediatr 67, 757–763 (2000). https://doi.org/10.1007/BF02723936

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02723936

Key words

Search

Navigation